GenSight Biologics Announces Annual General Meeting to Take Place on May 19, 2026

Procedures for obtaining preparatory documents for the General Meeting are described below. PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that it will hold its Annual General Meeting on May 19, … [Read more…]

Preparing Tomorrow’s Doctors: Zucker School of Medicine Leaders Share Transformative Blueprint in “Revolutionizing Medical Education”

Book provides techniques for improving student outcomes and physician capability through innovative curriculum that replaces traditional teaching methods NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Roughly 20 years ago a new medical school turned medical education upside down by reimagining how future physicians are trained. Today, that school, the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, … [Read more…]

Dubai’s Medcare Hospital Becomes the World’s First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US

DUBAI, United Arab Emirates–(BUSINESS WIRE)–Medcare Royal Speciality Hospital (MRSH) in Dubai has become the world’s first hospital outside the USA, to offer a newly licensed intrathecal gene therapy – Itvisma, to adult patients with Spinal Muscular Atrophy (SMA). This one-time treatment was recently administered to a 22-year-old Egyptian patient, who was diagnosed at 18 months … [Read more…]

Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke

The Yankees, Red Sox, Phillies, Braves, Astros, Cardinals, Giants, Padres, and Angels are joining Merck to help educate fans about high bad cholesterol and how it may increase the risk of heart attack or stroke RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a collaboration with … [Read more…]

Roquette Showcases Its Expanded Consumer Healthcare Capabilities at Vitafoods Europe 2026

Experts will share insights on consumer ready innovations for everyday health at booth 3F112 LILLE, France–(BUSINESS WIRE)–Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will present its expanded portfolio at Vitafoods Europe 2026 which is taking place from May 5 to May 7 in Barcelona. Roquette’s offering is designed to help consumer … [Read more…]

MarinHealth Launches New Women’s Lifelong Health and Wellness Clinic to Support Women Through Midlife and Beyond

New program expands women’s health services with specialized care for menopause, hormonal health, and long-term wellness GREENBRAE, Calif.–(BUSINESS WIRE)–#Marin—MarinHealth today announced the launch of its Women’s Lifelong Health and Wellness Clinic, a new program designed to support women as they navigate the hormonal, cardiovascular, metabolic, mental and preventive health needs that often emerge in midlife … [Read more…]

Ladenburg Thalmann Expands Investment Banking Platform with Biotechnology Specialist Dr. Aydin Huseynov, M.D., CFA

NEW YORK–(BUSINESS WIRE)–Ladenburg Thalmann & Co. Inc. (“Ladenburg Thalmann”), a leading middle-market investment bank providing investment banking, equity research, and institutional sales and trading services, today announced that Aydin Huseynov, M.D., CFA, has joined the firm’s Healthcare Investment Banking Group as Managing Director, Biotechnology Investment Banking Specialist. Dr. Huseynov will focus on the continued expansion … [Read more…]

Post Durnell Argument Scenario Statements – Attributable to Monsanto

LEVERKUSEN, Germany & ST. LOUIS–(BUSINESS WIRE)–“We appreciate the Court’s careful consideration of FIFRA’s Uniformity language and how its federal preemption provision applies to state-based label warnings. “We believe the U.S. Government and the Company made persuasive arguments that state-based warning claims ‘in addition to or different from’ warning labels approved by EPA under FIFRA, as … [Read more…]

Netsmart Showcases Proven Impact of Meaningful AI for Community-Based Care Providers at NatCon26

OVERLAND PARK, Kan.–(BUSINESS WIRE)–#ArtificialIntelligence—Netsmart, an industry-leading technology platform company with a suite of solutions and services for community-based providers, announces its participation at the National Council for Mental Wellbeing 2026 Conference (NatCon26) taking place April 27-29 in Denver. Marking nearly two decades of collaboration with the National Council, Netsmart reinforces its long-standing commitment to its … [Read more…]

Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa

— SOLOSEC® (secnidazole) 2g Oral Granules is an FDA-Approved Single-Dose Oral Treatment for Bacterial Vaginosis and Trichomoniasis — SAN DIEGO–(BUSINESS WIRE)–$EVFM #BV–Women’s health innovator Evofem Biosciences, Inc. (OTCID: EVFM) (Evofem or the Company) today announced that it has entered into an exclusive Distribution Agreement with Clovis Davis Pharmaceuticals, LLC, a distributor of pharmaceutical and related … [Read more…]